The pharmacokinetic measure describing the speed at which circulating cortisol, the primary glucocorticoid, is metabolized and eliminated from the systemic circulation, typically expressed as a half-life or total body clearance. An abnormal rate, whether too rapid or too slow, indicates altered hepatic function or changes in cortisol receptor activity. Monitoring this rate offers insight into the efficiency of the body’s stress hormone handling capacity. Precise clearance is necessary to prevent prolonged tissue exposure.
Origin
This term is a direct application of pharmacokinetic principles to the adrenal steroid cortisol. ‘Clearance’ refers to the irreversible removal from the plasma, usually via hepatic metabolism to inactive glucuronide or sulfate conjugates. Its clinical relevance stems from assessing the dynamic equilibrium of the HPA axis.
Mechanism
Cortisol clearance is predominantly mediated by hepatic enzymes, particularly the cytochrome P450 system, which perform hydroxylation and subsequent conjugation reactions. The rate is influenced by thyroid status, liver health, and the activity of specific steroid-metabolizing enzymes. Faster clearance may necessitate higher baseline production to maintain euthyroid status, whereas slower clearance can prolong the physiological effects of a given dose.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.